Expanding automated multiconformer ligand modeling to macrocycles and fragments
eLife · 2025
DOI: 10.7554/elife.103797 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2025. Verfasst von Jessica Flowers und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, United States. Hauptthemen laut MEDLINE: Macrocyclic Compounds, Models, Molecular. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Small molecule ligands exhibit a diverse range of conformations in solution. Upon binding to a target protein, this conformational diversity is reduced. However, ligands can retain some degree of conformational flexibility even when bound to a receptor. In the Protein Data Bank, a small number of ligands have been modeled with distinct alternative conformations that are supported by macromolecular X-ray crystallography density maps. However, the vast majority of structural models are fit to a single-ligand conformation, potentially ignoring the underlying conformational heterogeneity present in the sample. We previously developed qFit-ligand to sample diverse ligand conformations and to select a parsimonious ensemble consistent with the density. While this approach indicated that many ligands populate alternative conformations, limitations in our sampling procedures often resulted in non-physical conformations and could not model complex ligands like macrocycles. Here, we introduce several improvements to qFit-ligand, including integrating RDKit for stochastic conformational sampling. This new sampling method greatly enriches low-energy conformations of small molecules and macrocycles. We further extended qFit-ligand to identify alternative conformations in PanDDA-modified density maps from high-throughput X-ray fragment screening experiments, as well as single-particle cryo-electron microscopy density maps. The new version of qFit-ligand improves fit to electron density and reduces torsional strain relative to deposited single-conformer models and our prior version of qFit-ligand. These advances enhance the analysis of residual conformational heterogeneity present in ligand-bound structures, which can provide important insights for the rational design of therapeutic agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, United States.
- Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, United States.
- Atomwise Inc, San Francisco, United States.
ORCID-Profile: Jessica Flowers, Nathaniel Echols, Galen J Correy, Takaya Togo, Adam R Renslo, Henry van den Bedem, James S Fraser, Stephanie A Wankowicz
Förderung
- NIGMS NIH HHS
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
- National Institute of General Medical Sciences
Zitieren
APA
Flowers, J., Echols, N., Correy, G. J., Jaishankar, P., Togo, T., Renslo, A. R., van den Bedem, H., Fraser, J. S., & Wankowicz, S. A. (2025). Expanding automated multiconformer ligand modeling to macrocycles and fragments. eLife. https://doi.org/10.7554/elife.103797
Vancouver
Flowers J, Echols N, Correy GJ, Jaishankar P, Togo T, Renslo AR, et al. Expanding automated multiconformer ligand modeling to macrocycles and fragments. eLife. 2025. doi:10.7554/elife.103797
BibTeX
@article{Flowers2025,
author = {Flowers, Jessica and Echols, Nathaniel and Correy, Galen J and Jaishankar, Priyadarshini and Togo, Takaya and Renslo, Adam R and van den Bedem, Henry and Fraser, James S and Wankowicz, Stephanie A},
title = {Expanding automated multiconformer ligand modeling to macrocycles and fragments},
journal = {eLife},
year = {2025},
doi = {10.7554/elife.103797}
}
EUVIMED